Skip to content
Disclosery

MIC Capital Management UK LLP

Follow

13F filer, CIK 1889830, LONDON, United Kingdom

MIC Capital Management UK LLP reported $441,295,859 across 13 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 96.39% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001889830-26-000001

Period
2025-12-31
Reported value
$441M
Holdings
13
Top 10 weight
96.39%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HAYWreduced-1,556,573-$24M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001889830-26-000001, largest first. % of portfolio is the value over $441,295,859, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HAYWHAYWARD HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,764,660 shares; 2024Q4: 9,997,545 shares; 2025Q1: 9,997,545 shares; 2025Q2: 10,548,539 shares; 2025Q3: 9,879,506 shares; 2025Q4: 8,322,933 shares 8,322,933$129M29.14%-1,556,573Timeline
KLARKLARNA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,714,928 shares; 2025Q4: 2,714,928 shares 2,714,928$78.5M17.79%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 508,569 shares; 2024Q4: 508,569 shares; 2025Q1: 508,569 shares; 2025Q2: 508,569 shares; 2025Q3: 508,569 shares; 2025Q4: 508,569 shares 508,569$40.5M9.18%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,451,758 shares; 2024Q4: 9,644,033 shares; 2025Q1: 9,644,032 shares; 2025Q2: 9,644,032 shares; 2025Q3: 9,644,032 shares; 2025Q4: 9,644,032 shares 9,644,032$39.4M8.94%0Timeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,412,946 shares; 2024Q4: 1,412,946 shares; 2025Q1: 1,412,946 shares; 2025Q2: 1,412,946 shares; 2025Q3: 1,412,946 shares; 2025Q4: 1,412,946 shares 1,412,946$33.3M7.55%0Timeline
QSRRESTAURANT BRANDS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 386,203 shares; 2024Q4: 386,203 shares; 2025Q1: 386,203 shares; 2025Q2: 386,203 shares; 2025Q3: 386,203 shares; 2025Q4: 386,203 shares 386,203$26.4M5.97%0Timeline
GRABGRAB HOLDINGS LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000,000 shares; 2024Q4: 5,000,000 shares; 2025Q1: 5,000,000 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,000,000 shares; 2025Q4: 5,000,000 shares 5,000,000$24.9M5.65%0Timeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 150,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares 150,000$22M4.98%0Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 33,300 shares; 2024Q4: 33,300 shares; 2025Q1: 33,300 shares; 2025Q2: 33,300 shares; 2025Q3: 33,300 shares; 2025Q4: 33,300 shares 33,300$22M4.98%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,000 shares; 2024Q4: 66,000 shares; 2025Q1: 66,000 shares; 2025Q2: 66,000 shares; 2025Q3: 66,000 shares; 2025Q4: 66,000 shares 66,000$9.74M2.21%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,460,700 shares; 2024Q4: 4,460,700 shares; 2025Q1: 4,460,700 shares; 2025Q2: 4,460,700 shares; 2025Q3: 4,460,700 shares; 2025Q4: 4,460,700 shares 4,460,700$7.98M1.81%0Timeline
ACHRARCHER AVIATION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 700,000 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares; 2025Q3: 700,000 shares; 2025Q4: 700,000 shares 700,000$5.26M1.19%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 87,028 shares; 2025Q3: 87,028 shares; 2025Q4: 87,028 shares 87,028$2.68M0.61%0Timeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001889830-26-000001 base2026-02-17acceptance time not in the bulk data set